These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 28090074)

  • 1. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
    Zhang C; Zhang Z; Zhang S; Wang W; Hu P
    Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
    Cui L; Zhao J; Liu J
    Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway.
    Zheng L; Liu Y; Pan J
    Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):890-898. PubMed ID: 28981601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt/β-catenin signaling.
    Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
    Biochem Biophys Res Commun; 2015 Nov; 467(1):14-20. PubMed ID: 26427870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Wnt/β-catenin by anthelmintic drug niclosamide overcomes paclitaxel resistance in esophageal cancer.
    Wei W; Liu H; Yuan J; Yao Y
    Fundam Clin Pharmacol; 2021 Feb; 35(1):165-173. PubMed ID: 32579788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
    Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
    Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Casein kinase 1α-dependent inhibition of Wnt/β-catenin selectively targets nasopharyngeal carcinoma and increases chemosensitivity.
    Li J; Jiang Y; Wang P; Ke S; Yang L; Shen Y
    Anticancer Drugs; 2019 Aug; 30(7):e0747. PubMed ID: 31305293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer.
    Xu W; Lacerda L; Debeb BG; Atkinson RL; Solley TN; Li L; Orton D; McMurray JS; Hang BI; Lee E; Klopp AH; Ueno NT; Reuben JM; Krishnamurthy S; Woodward WA
    PLoS One; 2013; 8(8):e71508. PubMed ID: 24013655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling.
    Zhang H; Jiao Y; Shi C; Song X; Chang Y; Ren Y; Shi X
    Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):532-539. PubMed ID: 29701777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic Inhibition of β-Catenin With Pyrvinium Inhibits Murine and Human Models of Wilms Tumor.
    Polosukhina D; Love HD; Moses HL; Lee E; Zent R; Clark PE
    Oncol Res; 2017 Nov; 25(9):1653-1664. PubMed ID: 28695795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated β-catenin activity contributes to carboplatin resistance in A2780cp ovarian cancer cells.
    Barghout SH; Zepeda N; Xu Z; Steed H; Lee CH; Fu Y
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):173-8. PubMed ID: 26522223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer.
    Arend RC; Londoño-Joshi AI; Samant RS; Li Y; Conner M; Hidalgo B; Alvarez RD; Landen CN; Straughn JM; Buchsbaum DJ
    Gynecol Oncol; 2014 Jul; 134(1):112-20. PubMed ID: 24736023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of R-spondin 1 through activating Wnt/β-catenin in the growth, survival and migration of ovarian cancer cells.
    Liu Q; Zhao Y; Xing H; Li L; Li R; Dai J; Li Q; Fang S
    Gene; 2019 Mar; 689():124-130. PubMed ID: 30572097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α.
    Thorne CA; Hanson AJ; Schneider J; Tahinci E; Orton D; Cselenyi CS; Jernigan KK; Meyers KC; Hang BI; Waterson AG; Kim K; Melancon B; Ghidu VP; Sulikowski GA; LaFleur B; Salic A; Lee LA; Miller DM; Lee E
    Nat Chem Biol; 2010 Nov; 6(11):829-36. PubMed ID: 20890287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathway.
    Zhang Q; Zhang B; Sun L; Yan Q; Zhang Y; Zhang Z; Su Y; Wang C
    Cell Biochem Funct; 2018 Jun; 36(4):194-202. PubMed ID: 29653464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway.
    Li B; Cai S; Zhao Y; He Q; Yu X; Cheng L; Zhang Y; Hu X; Ke M; Chen S; Zou M
    Oncotarget; 2016 Dec; 7(49):81026-81048. PubMed ID: 27835587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
    Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
    Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of PKCδ Induces Prostate Cancer Resistance to Paclitaxel through Activation of Wnt/β-Catenin Pathway and Mcl-1 Accumulation.
    Flores ML; Castilla C; Gasca J; Medina R; Pérez-Valderrama B; Romero F; Japón MA; Sáez C
    Mol Cancer Ther; 2016 Jul; 15(7):1713-25. PubMed ID: 27196755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.